Scott A. Armstrong

Scott A. Armstrong is Senior Vice President for Drug Discovery and Chief Research Strategy Officer at Dana-Farber Cancer Institute, and David G. Nathan Professor of Pediatrics at Harvard Medical School. Researches chromatin-based mechanisms in leukemia development.

Leadership: Served as President of Dana-Farber/Boston Children's Cancer Center (2019-2025) and Chair of Pediatric Oncology (2016-2025). Former director of Center for Epigenetics Research at Memorial Sloan Kettering.

Research focus: Relationship between leukemia and hematopoietic stem cells; chromatin regulation of oncogenic gene expression. Developed FDA-approved therapeutics targeting chromatin complexes.

Awards: Elected to National Academy of Medicine and AAAS Fellowship for contributions to epigenetics and cancer drug development.

Leads therapeutic discovery initiatives translating basic research into clinical applications for pediatric and adult cancers.